Total Funding
50
3
Total FundingPrivate Equity raised
Growth Score
-5 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43588
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies.
- Edd Fleming: Executive Vice President, Commercialization
James Boylan: Chief Executive OfficerPast Role: Merrill Lynch, Managing Director
About the Company
Enavate Sciences is committed to investing in and supporting the strategic growth of innovative therapeutic and enabling technology companies.
